Ankylosing Spondylitis

Help Us Understand the Effects of Ankylosing Spondylitis in Pregnancy

Many people need to take medication during pregnancy to appropriately manage their ankylosing spondylitis. Yet fewer than 10% of medications have enough information to determine their safety for use in pregnancy — this is where we need you as our partner!

Do you have ankylosing spondylitis? Are you currently pregnant? If you answered “yes” to both of these questions, you may be able to help us advance our knowledge of how ankylosing spondylitis and its management can affect a pregnancy and a developing baby.

Will you take the step and become our partner? Make an impact on the health of future families today by joining our Ankylosing Spondylitis & Pregnancy Study!

Join a Study
REfer A PAtient

Ankylosing Spondylitis

Thank you for your interest, but unfortunately, we are no longer enrolling participants in this study. However, you may be eligible to participate in one of our other ongoing studies. Fill out your information using our Join a Study form, and a member of our team will contact you.

We’re Collecting Info on CIMZIA® When Taken in Pregnancy

MotherToBaby is currently enrolling participants into an observational study examining the use of CIMZIA® (certolizumab pegol) when taken during pregnancy to treat ankylosing spondylitis, Crohn’s disease, psoriasis, psoriatic arthritis, and/or rheumatoid arthritis. Our research is by observation only—we will not ask you to take or change any medications. If you join our CIMZIA® study, our team will simply collect some information about your pregnancy and your baby’s development for a period of time after birth. If you have taken CIMZIA® during your current pregnancy, you may qualify for this important study.

Find out more below!

Join a Study
REfer A PAtient

Questions?

To connect with our research team, please contact us at

Phone | 877.311.8972
Email | mothertobaby@health.ucsd.edu

We’re open Monday – Thursday from 7am – 7pm and Friday 7am – 6pm Pacific, excluding public holidays.

You can also visit our Frequently Asked Questions to learn more about participating in our studies.

How Our Studies Work

MotherToBaby Computer Icon

Parent-To-Be Enrolls in Study 

MotherToBaby File Icon

We Gather Info about the Pregnancy 

MotherToBaby Insights Icon

Discoveries & Insights Gained 

What’s Involved?

Our study includes:
• 1-3 phone interviews during your pregnancy and at least 1 interview after you have your baby.
• Your permission to obtain a copy of your and your baby’s medical records from your healthcare providers.
• An opportunity to receive a specialized, non-invasive exam of your baby with a study doctor

MotherToBaby Pregnancy Women Intro Block

What is MotherToBaby Pregnancy Studies?

MotherToBaby Pregnancy Studies is a research program seeking to understand how certain medications, vaccines, or health conditions may affect pregnancy. Our research will help people who are pregnant and/or breastfeeding and health providers make informed treatment decisions. All of our studies are observational: we will never ask someone to take or change any aspect of their current health routine.

Who Leads MotherToBaby Pregnancy Studies?

Christina Chambers, PhD, MPH is the lead investigator for MotherToBaby Pregnancy Studies, which are coordinated by UC San Diego’s Center for Better Beginnings. She is a world‐renowned perinatal epidemiologist and a Professor of Pediatrics and Family and Preventive Medicine at the UC San Diego. Her interests are in the areas of birth defects and other pregnancy outcomes, with a special focus on exposures that can cause birth defects.

“Every person deserves to know if their health conditions or the medication they need to take could affect their baby during pregnancy. We are committed to bringing you better information for healthier outcomes.”

– Christina Chambers, PhD, MPH

Will you take the next step and help us learn more about the use of CIMZIA® during pregnancy?

Ankylosing Spondylitis
December 6, 2016		 page {PAGENO} of {PAGETOTAL}